These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3002263)

  • 1. Rotavirus infections and their prevention by vaccination.
    Vesikari T
    Antiviral Res; 1985; Suppl 1():293-300. PubMed ID: 3002263
    [No Abstract]   [Full Text] [Related]  

  • 2. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.
    Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ
    Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus: the major etiologic agent of severe infantile diarrhea may be controllable by a "Jennerian" approach to vaccination.
    Kapikian AZ; Flores J; Hoshino Y; Glass RI; Midthun K; Gorziglia M; Chanock RM
    J Infect Dis; 1986 May; 153(5):815-22. PubMed ID: 3009632
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-rotavirus vaccinations].
    Schmitz J
    Arch Pediatr; 1999 Sep; 6(9):979-84. PubMed ID: 10519034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.
    Bernstein DI; Glass RI; Rodgers G; Davidson BL; Sack DA
    JAMA; 1995 Apr; 273(15):1191-6. PubMed ID: 7707626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virological and serological aspects of immune resistance to rotavirus gastroenteritis.
    Chiba S; Nakata S; Ukae S; Adachi N
    Clin Infect Dis; 1993 Mar; 16 Suppl 2():S117-21. PubMed ID: 8384012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine.
    Vesikari T; Isolauri E; D'Hondt E; Delem A; André FE; Zissis G
    Lancet; 1984 May; 1(8384):977-81. PubMed ID: 6143964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines against viral diarrhoea.
    Flores J; Kapikian AZ
    Baillieres Clin Gastroenterol; 1990 Sep; 4(3):675-93. PubMed ID: 1962729
    [No Abstract]   [Full Text] [Related]  

  • 9. Neonatal rotavirus infection: possible effect on prevalence of severe diarrhoea in a community.
    Bishop RF; Barnes GL
    J Paediatr Child Health; 1997 Feb; 33(1):80. PubMed ID: 9069052
    [No Abstract]   [Full Text] [Related]  

  • 10. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.
    Vesikari T; Rautanen T; Varis T; Beards GM; Kapikian AZ
    Am J Dis Child; 1990 Mar; 144(3):285-9. PubMed ID: 2154925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live attenuated human rotavirus vaccine, Rotarix.
    Bernstein DI
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):188-94. PubMed ID: 17055369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccine.
    Simasathien S; Migasena S; Samakoses R; Pitisuttitham P; Sangaroon P; Aree C; Bishop R; Bugg H; Davidson BL; Vesikari T
    Pediatr Infect Dis J; 1994 Jul; 13(7):590-6. PubMed ID: 7970945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of protection of pentavalent rotavirus vaccination in Nicaragua.
    Patel M; Pedreira C; De Oliveira LH; Umaña J; Tate J; Lopman B; Sanchez E; Reyes M; Mercado J; Gonzalez A; Perez MC; Balmaceda A; Andrus J; Parashar U
    Pediatrics; 2012 Aug; 130(2):e365-72. PubMed ID: 22753550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants.
    Zoppi G; Ferrarini G; Rigolin F; Bogaerts H; André FE
    Helv Paediatr Acta; 1986 Aug; 41(3):203-8. PubMed ID: 3019954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotavirus vaccines.
    Indian J Pediatr; 1989; 56(4):548-50. PubMed ID: 2561284
    [No Abstract]   [Full Text] [Related]  

  • 16. The pentavalent rotavirus vaccine, RotaTeq.
    Matson DO
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):195-9. PubMed ID: 17055370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in development of a rotavirus vaccine for prevention of severe diarrheal illness of infants and young children.
    Kapikian AZ; Flores J; Vesikari T; Ruuska T; Madore HP; Green KY; Gorziglia M; Hoshino Y; Chanock RM; Midthun K
    Adv Exp Med Biol; 1991; 310():255-64. PubMed ID: 1667066
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of candidate rotavirus vaccines.
    Bishop RF
    Vaccine; 1993; 11(2):247-54. PubMed ID: 8382418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rotavirus vaccine.
    Offit PA
    J Clin Virol; 1998 Dec; 11(3):155-9. PubMed ID: 9949951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine.
    Lanata CF; Black RE; del Aguila R; Gil A; Verastegui H; Gerna G; Flores J; Kapikian AZ; Andre FE
    J Infect Dis; 1989 Mar; 159(3):452-9. PubMed ID: 2536789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.